Nicole K Paulk is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of gene therapy, particularly in the development of adeno-associated virus (AAV) capsids. With a total of 3 patents, her work focuses on enhancing the efficacy of gene delivery systems.

Latest Patents

One of her latest patents is titled "Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies." This invention relates to variant AAV capsid polypeptides that exhibit an enhanced neutralization profile, increased transduction, and/or tropism in human liver tissue or hepatocyte cells. Another notable patent is "Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism." This invention also involves variant AAV capsid polypeptides that show increased transduction and/or tropism in human muscle tissue or cells.

Career Highlights

Nicole K Paulk is affiliated with Leland Stanford Junior University, where she conducts her research and development work. Her innovative approaches have positioned her as a key figure in advancing gene therapy technologies.

Collaborations

She collaborates with notable professionals in her field, including Mark A Kay, to further enhance the impact of her research.

Conclusion

Nicole K Paulk's contributions to gene therapy through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.